This firm currently holds 4.27
M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest Merus N is not taking enough advantage from borrowing. The company has a current ratio of 4.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Our advice module complements current
analysts and expert consensus on Merus N V. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time.
We determine the current worth of Merus BV using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Merus BV based exclusively on its
fundamental and basic
technical indicators. By analyzing Merus BV's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of
Merus BV's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merus BV. We calculate exposure to Merus BV's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Merus BV's related companies.
Merus BV Investment Alerts
Merus investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Merus BV performance across your portfolios.Please check all
investment alerts for Merus
Merus BV Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare Merus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merus BV competition to find
correlations between indicators driving the intrinsic value of Merus.
Merus BV Gross Profit
Merus BV Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Merus BV previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Merus BV Gross Profit growth over the last 10 years. Please check Merus BV's
gross profit and other
fundamental indicators for more details.
Detailed Outlook On Merus BV
Merus N V reported the previous year's revenue of 28.72
M. Net Loss for the year was (82.97
M) with loss before overhead, payroll, taxes, and interest of (24.55
M).
Margins Breakdown
Merus profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Merus N itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Merus N profit margins.
| EBITDA Margin | (2.15) |
| Gross Margin | 0.89 |
| Profit Margin | (2.2) |
Merus N Average Equity is relatively stable at the moment. Merus N Earnings before Tax is decreasing over the last 8 years. The previous year's value of Merus N Earnings before Tax was -53,366,139. Additionally, Merus N Earnings Before Interest Taxes and Depreciation Amortization USD is relatively stable at the moment. Merus N Average Equity is relatively stable at the moment. Merus N Earnings before Tax is decreasing over the last 8 years. Additionally, Merus N Earnings Before Interest Taxes and Depreciation Amortization USD is decreasing over the last 8 years. The previous year's value of Merus N Earnings Before Interest Taxes and Depreciation Amortization USD was -52,261,082.
Our perspective of the latest Merus N spike
Semi variance is down to 6.0. It may connote a possible volatility fall. As of the 9th of January, Merus N secures the Risk Adjusted Performance of 0.1446,
mean deviation of 2.37, and Downside Deviation of 2.79. In connection with
fundamental indicators, the
technical analysis model lets you check existing technical drivers of Merus N V, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We are able to interpolate and collect nineteen
technical drivers for Merus N, which can be compared to its peers in the industry. Please verify
Merus N V variance and
potential upside to decide if Merus N V is priced some-what accurately, providing market reflects its recent price of 20.73 per share. Given that Merus N V has
jensen alpha of 0.3924, we recommend you to check Merus N's last-minute market performance to make sure the company can sustain itself at a future point.
While some firms under the biotechnology industry are still a bit expensive, Merus N may offer a potential longer-term growth to retail investors. The bottom line, as of the 9th of January 2021, we see that Merus N slowly supersedes the market. The enterprise is
fairly valued with
very small chance of financial distress within the next 24 months. Our present 30 days buy-or-sell advice on the enterprise is
Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Merus BV. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
